AF
Aafreen Fayas Sayed
About Aafreen Fayas Sayed
Data last updated:
Aafreen Fayas Sayed is a Director at Nugenesys Pharmaceuticals Private Limited (since 2024). The company operates in Paper. Nugenesys Pharmaceuticals Private Limited reported revenue of ₹9.8 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nugenesys Pharmaceuticals Private Limited U21002MH2024PTC436328 | Director | 12 Dec 2024 | 2024 | ₹9.8 Lakh (FY 2025) | Active |
Board colleagues of Aafreen Fayas Sayed
| Name | DIN | Company | Designation |
|---|---|---|---|
| Saba Shoyeb Mandlekar | 11188092 | Nugenesys Pharmaceuticals Private Limited | Additional Director |
| Shoyeb Abdul Gafoor Mandlekar | 08581970 | Nugenesys Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aafreen Fayas Sayed
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aafreen Fayas Sayed
Aafreen Fayas Sayed currently holds 1 directorship: Nugenesys Pharmaceuticals Private Limited (Director, since 12 Dec 2024, revenue ₹9.8 Lakh (FY 2025)).
Aafreen Fayas Sayed was first appointed on 12 Dec 2024 as Director at Nugenesys Pharmaceuticals Private Limited.
The current boards of Aafreen Fayas Sayed's companies include Saba Shoyeb Mandlekar (Nugenesys Pharmaceuticals Private Limited), Shoyeb Abdul Gafoor Mandlekar (Nugenesys Pharmaceuticals Private Limited).